Analyst Ratings for Acorda Therapeutics Inc. (ACOR)Updated: 2017-07-27
Shares of Acorda Therapeutics Inc. (NASDAQ:ACOR) have received a consensus rating of Overweight from Wall Street analysts. A consensus rating of Overweight was previously issued for ACOR last month.
8 analysts issued ratings on the stock, where 2 gave ACOR a buy rating, 0 issued an overweight rating, 6 gave a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has decreased by 1. Meanwhile, the number of analysts pessimistic about the company has increased by 0.
Investment analysts gave a few price targets for ACOR. The most optimistic analyst gave a price target of 35, implying potential capital gains of 61.29 percent. The lowest price target was 17, which equates to a potential downside of -21.66 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.
In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 3.15 percent. That number becomes 75.62 percent if we expand the time horizon to include the past 3 months instead of just one. Over the past 30 days, FY earnings estimates have also changed upwards by 2.05 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 26.1 percent.
Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. Over the past month, 1 analysts increased their quarterly estimates, while 2 analysts revised their estimates downwards. During this time, 1 analysts made positive revisions in their estimates for this fiscal year's earnings, while 2 analysts made negative revisions to their fiscal year's estimates.
In the last 52-weeks, ACOR has achieved a high of 33.00 and a low of 13.60. The current market price is above the trailing year's low by 59.56 percent, and 34.24 percent lower than its 52-week high. ACOR has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The ACOR value stock report compares ACOR to some of its peers using value stock charts. The stock has a market capitalization of $1.05 billion. ACOR is estimated to release their earnings results for the quarter on 0000-00-00, days from today.